DHM AS A FLAVONOID

What a Flavonoid Is

Flavonoids are a large family of polyphenolic compounds produced by plants as secondary metabolites, mostly for defense against ultraviolet light and microbial attack. The family includes flavones, flavonols, flavanones, flavanols (catechins), isoflavones, anthocyanidins, and flavanonols. Most of them share a common 15-carbon backbone (two aromatic rings connected by a three-carbon bridge that often forms a third ring), and they differ from each other in the oxidation state of the central ring and in which positions carry hydroxyl groups¹.

DHM (dihydromyricetin, also called ampelopsin) sits in the flavanonol subfamily. The "dihydro" prefix means it has two extra hydrogens compared to the parent flavonol myricetin -- specifically a saturated 2,3 bond in the central ring rather than a double bond. The five hydroxyl groups distributed around the ring system are what give DHM its high antioxidant activity and its poor water solubility at the same time³.

Why the Chemistry Matters

The phenolic hydroxyl groups are the active sites for antioxidant chemistry. They donate electrons to neutralize reactive oxygen species, and the more hydroxyls a flavonoid has, the higher its antioxidant capacity tends to be. DHM has five, which puts it near the top of the flavonoid family for this kind of activity². The same hydroxyls also make the molecule polar enough to dissolve poorly in fats but not polar enough to dissolve well in water, which is the chemical reason DHM has a 4 percent oral bioavailability³.

The structural classification predicts the absorption pattern reasonably well, in the published flavonoid pharmacology at least. (this is the part of the chemistry that explains why the supplement industry struggles with this category in general, not just with DHM specifically.)

What DHM Does Mechanistically as a Flavonoid

DHM's biological activity has both an antioxidant component (shared with other heavily-hydroxylated flavonoids) and a more specific receptor-and-enzyme component that distinguishes it from related compounds. The 2012 UCLA paper showed that DHM acts on GABA-A receptors and induces ADH/ALDH expression, which are not generic flavonoid effects⁴. The flavonoid family includes hundreds of structurally similar molecules, but only a few have the specific binding profile that DHM does at these targets².

The 2017 review of DHM in health summarizes the broader pharmacological landscape -- antioxidant, anti-inflammatory, anti-diabetic, hepatoprotective, neuroprotective, and several other documented activities, most of which trace back to the flavanonol structure but get amplified by DHM's specific hydroxyl arrangement².

The Bioavailability Trade-Off

The chemistry that makes DHM biologically active is also the chemistry that makes it hard to deliver. The hydroxyl groups that scavenge ROS are the same groups that drive poor membrane permeability. Solving the bioavailability problem without losing the activity is the central formulation challenge for any DHM product, and it is part of why the H180 formula pairs DHM with fulvic acid as a chelation-based delivery agent³. The chemistry adn the bioavailability problem are linked at the molecular level, which is why formulation choices matter so much.

What This Page Is Not Claiming

We are not claiming DHM is the only useful flavonoid for alcohol metabolism, or that the flavanonol structure alone predicts every pharmacological effect. The claim is narrower -- DHM's specific structural classification predicts its activity profile reasonably well, and understanding the chemistry helps explain both what DHM can do and where its formulation limits come from.

For the practical implications of the bioavailability problem, see DHM Bioavailability. For the broader context on flavonoids and alcohol, see Flavonoids and Alcohol.